Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03112876 · ClinicalTrials.gov registry record
Sebum Collection and Skin Barrier Function Analysis
A clinical trial, sponsored by University of California, Davis.
- Completed
- Registry status
- 41
- Enrollment target
NCT03112876: Completed study, sponsored by University of California, Davis.
NCT03112876 is a clinical trial that has completed, run by University of California, Davis. The registered enrollment target is 41 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03112876 has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- 41 participants
- Enrollment target
Study Summary
The goal is this study is to evaluate how the skin surface lipid composition is correlated with overall sebum production, barrier function, and inflammatory disease status. We hypothesize that there will be differences in the skin surface composition among subjects of various groups: 1. Young vs older healthy population 2. Atopic dermatitis vs Acne vs Healthy controls 3. Active smokers vs non-smoker controls
Primary Outcome
The lipid profile of the subject group will be evaluated through the use of painless tapes that will be applied to the skin.
Interventions
- OTHER Skin Surface Lipid Collection and Skin Barrier Function
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2014-06-27 |
| Est. Completion | 2016-02-26 |
What the finished NCT03112876 record still lists
NCT03112876 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 41 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Skin Surface Lipid Collection and Skin Barrier Function is the first listed.
NCT03112876 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03112876 about?
NCT03112876 is a clinical study titled "Sebum Collection and Skin Barrier Function Analysis". The goal is this study is to evaluate how the skin surface lipid composition is correlated with overall sebum production, barrier function, and inflammatory disease status. We hypothesize that there will be differences in the skin surface composition among subjects of various groups: 1. Young vs ol...
What is the current status of trial NCT03112876?
This trial is currently completed. The enrollment target is 41 participants. The study started on 2014-06-27. Estimated completion is 2016-02-26.
What interventions are being tested in trial NCT03112876?
The interventions under investigation include: Skin Surface Lipid Collection and Skin Barrier Function (OTHER).
Who is sponsoring clinical trial NCT03112876?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI